FDC: Receipt Of Establishment Inspection Report (EIR) From US FDA With No Observations (Zero 483 S) As Closure Of Inspection Conducted At Company''s Manufacturing Facility Located At Baddi Himachal Pradesh.

This is further to the intimation given by the Company dated August 23 2024 the US-FDA had Conducted an inspection at Companys manufacturing facility located at Baddi Himachal Pradesh in the month of August 2024.